Fundamental Analysis
44 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +19.8% | +12.4% | 3 / 3 | +27.1% | -5.76 pp | -2.51 pp | +11.5% | 0.01 | 5.07 | 156 | +27,1% | 64,0 | +19,8% | 5.07 | 7.00 | −27,6% |
| Pts | 0 | 0 | 12 | 12 | 0 | 0 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 13.000 (close price on 2026-10-19)EPS (TTM): 2.564
Financial charts
1.Revenue & growth
VND bn156Q2/26
1.Revenue & growth
VND bn156Q2/26
2.Profit & growth
VND bn63,9Q2/26
3.Profit mix (Penman)
VND bn247Q2/26
4.Margins & cost structure
%29.8%Q2/26
5.Returns & cash cycle
% · days4.8%Q2/26
6.Earnings quality & cash
VND bn29,1Q2/26
7.Asset structure
VND bn2.550Q2/26
8.Funding & debt health
VND bn · times2.550Q2/26
9.Revenue backlog
VND bn442Q2/26
10.Valuation
times · %5,1×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %738Q2/26
Adjusted EPS growth, latest quarter
19.8%
Average adjusted EPS growth, 3 quarters
12.4%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26